 |
| Sarah McCabe |
JPA Health has hired Sarah McCabe to helm its newly launched investor relations practice.
She has more than 20 years of financial communications experience, which includes a 15-year stint at Stern Investor Relations. She was managing director at Stern.
The JPA IR unit will target companies in the pharmaceutical, biotechnology, and medical device sectors.
Carrie Jones, CEO of JPA, said investor relations “was a missing piece of the puzzle for our life sciences offerings, and we are delighted to now provide this capability to support our clients’ success.”
McCabe will report to Colleen Carter, head of the life sciences group.
JPA Health ranks No. 12 in O’Dwyer’s rankings of healthcare firms with 2023 fees of $24.3M.
Stagwell CEO Mark Penn reports Q3 net revenues jumped 6 percent to $614.5M, a record performance for a non-political period. Operating income soared 45.7 percent to $60.9M.
Joele Frank works for Klöckner Pentaplast as the German maker of plastic films declares Chapter 11. A successful reorganization would slash its its corporate debt by $1.5B.
Teneo represents Metsera, the New York City biotech focused on weight-control products, which is subject to a bidding war between heavyweights Novo Nordisk and Pfizer.
Haggie Partners is working the $7B takeover of the specialty insurer Convex by Canada’s Onex private equity fund and American International Group.
WPP reported Q3 revenues less pass-through costs tumbled 5.9 percent to $3.3B, a performance new CEO Cindy Rose called “unacceptable.”
